Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Name: Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.
Published: 2020
License: Public Domain

AstraZeneca · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

mobile-applications non-small-cell-lung-cancer nsclc

unresectable stage iii nsclc, nsclc, non-small cell lung cancer, durvalumab, stage iii, stage iiia, spirometer, spirometry, pros, mobile applications, digital applications, stage iiib

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 843796
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.